Press Release|

SHL Medical announces new logo and domain name

Newspage Rebranding Content

SHL Medical has launched a new logo and domain name as part of a global effort to consolidate our drug delivery offerings.

We will be taking a phased approach to implementing the updates. You will see immediate changes in our digital material, including our website, emails, and social media pages. This will be followed by gradual updates to our documentation, quality systems, as well as other physical assets.

Our original email addresses (name@shl-group.com) will still be in effect until further notice, but please assist us in updating our emails (name@shl-medical.com) in your Address Book.

We appreciate your kind support. If you have any questions, please do not hesitate to contact us.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems has announced a strategic partnership with Grand River Aseptic Manufacturing (GRAM), a highly regarded contract development and manufacturing organization (CDMO) specializing in sterile injectable biologics and scalable pharmaceutical manufacturing solutions tailored to diverse client needs.